The bradykinin B2 receptor mediates hypoxia/reoxygenation induced neuronal cell apoptosis through the ERK1/2 pathway

Neuroscience Letters

Volumn 450, Issue 1, 2009, Pages 40-44

  Tang, Min ^a,b   Cui, Mei ^a   Dong, Qiang ^a   Ren, Hui min ^a   Xiao, Bao guo ^a   Luo, Ben yan ^b   Shao, Yuan ^a   Liu, Ling ^a   Zhou, Hou guang ^a  

^a FUDAN UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

B2 receptor; Bradykinin; ERK; Hypoxia reoxygenation; Neuron

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; BRADYKININ; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR AGONIST; ICATIBANT; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; COMPETITIVE INHIBITION; CONTROLLED STUDY; HYPOXIA; NERVE CELL CULTURE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REOXYGENATION;

ANIMALS; APOPTOSIS; BRADYKININ; CELL HYPOXIA; CELLS, CULTURED; CULTURE MEDIA; FLAVONOIDS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEURONS; OXYGEN; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, BRADYKININ B2; REPERFUSION INJURY;

EID: 57549100843     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.10.110     Document Type: Article

References (30)

1. Abbott N.J. Inflammatory mediators and modulation of blood-brain barrier. Permeability Cell. Mol. Neurobiol. 20 (2000) 131-147
2. Adolfo Argañaraz G., Regina Perosa S., Cristina Lencioni E., Bader M., Abrão Cavalheiro E., da Graça M., Naffah-Mazzacoratti J.B., Pesquero J., and Antônio Silva Jr. Role of kinin B1 and B2 receptors in the development of pilocarpine model of epilepsy. Brain. Res. 1013 (2004) 30-39
3. Adomeit A., Graness A., Gross S., Seedorf K., Wetzker R., and Liebmann C. Bradykinin B(2) receptor-mediated mitogen-activated protein kinase activation in COS-7 cells requires dual signaling via both protein kinase C pathway and epidermal growth factor receptor transactivation. Mol. Cell. Biol. 19 (1999) 5289-5297
4. Bae S.W., Kim H.S., Cha Y.N., Park Y.S., Jo S.A., and Jo I. Rapid increase in endothelial nitric oxide production by bradykinin is mediated by protein kinase A signaling pathway. Biochem. Biophys. Res. Commun. 306 (2003) 981-987
5. Brewer G.J., Torricelli J.R., Evege E.K., and Price P.J. Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum free medium combination. J. Neurosci. Res. 35 (1993) 567-576
6. +) pathway. Free Radic. Biol. Med. 43 (2005) 702-710
7. Couture R., Harrisson M., Vianna R.M., and Cloutier F. Kinin receptors in pain and inflammation. Eur. J. Pharmacol. 429 (2001) 161-176
8. Greco S., Elia M.G., Muscella A., Romano S., Storelli C., and Marsigliante S. Bradykinin stimulates cell proliferation through an extracellular-regulated kinase 1 and 2-dependent mechanism in breast cancer cells in primary culture. J. Endocrinol. 186 (2005) 291-301
9. Gröger M., Lebesgue D., Pruneau D., Relton J., Kim S.W., Nussberger J., and Plesnila N. Release of bradykinin and expression of kinin B2 receptors in the brain: role for cell death and brain edema formation after focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 25 (2005) 978-989
10. Heitsch H. The therapeutic potential of bradykinin B2 receptor agonists in the treatment of cardiovascular disease. Expert Opin. Investig. Drugs 12 (2003) 759-770
11. Hsieh H.L., Wu C.Y., Hwang T.L., Yen M.H., Parker P., and Yang C.M. BK-induced cytosolic phospholipase A2 expression via sequential PKC-delta, p42/p44 MAPK, and NF-kappaB activation in rat brain astrocytes. J. Cell. Physiol. 206 (2006) 246-254
12. Ito H., Hayashi I., Izumi T., and Majima M. Bradykinin inhibits development of myocardial infarction through B2 receptor signalling by increment of regional blood flow around the ischaemic lesions in rats. Br. J. Pharmacol. 138 (2003) 225-233
13. Leeb-Lundberg L.M., Marceau F., Müller-Esterl W., Pettibone D.J., and Zuraw B.L. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol. Rev. 57 (2005) 27-77
14. Li H.J., Yin H., Yao Y.Y., Shen B., Bader M., Chao L., and Chao J. Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3β activation. Cardiovasc. Res. 73 (2007) 130-142
15. Liu B., Yu J., Taylor L., Zhou X., and Polgar P. Microarray and phosphokinase screenings leading to studies on ERK and JNK regulation of connective tissue growth factor expression by angiotensin II 1a and bradykinin B2 receptors in Rat1 fibroblasts. J. Cell. Biochem. 97 (2006) 1104-1120
16. Marceau F., Hess J.F., and Bachvarov D.R. The B1 receptors for kinins. Pharmacol. Rev. 50 (1998) 357-386
17. Park T.J., and Kim K.T. Activation of B2 bradykinin receptors by neurotensin. Cell. Signal. 15 (2003) 519-527
18. Regoli D., and Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 32 (1980) 1-46
19. Roux P.P., and Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 68 (2004) 320-344
20. Sharma J.N. The kallikrein-kinin system: from mediator of inflammation to modulator of cardioprotection. Inflammopharmacology 12 (2005) 591-596
21. Soukhova-OHare G.K., Zhang J.W.D., and Gozal J.Yu. Bradykinin B2 receptors mediate pulmonary sympathetic afferents induced reflexes in rabbits. Life Sci. 78 (2006) 1990-1997
22. Souza D.G., Lomez E.S., Pinho V., Pesquero J.B., Bader M., Pesquero J.L., and Teixeira M.M. Role of bradykinin B2 and B1 receptors in the local, remote, and systemic inflammatory responses that follow intestinal ischemia and reperfusion injury. J. Immunol. 172 (2004) 2542-2548
23. Wagner S., Kalb P., Lukosava M., Hilgenfeldt U., and Schwaninger M. Activation of the tissue kallikrein-kinin system in stroke. J. Neurol. Sci. 202 (2002) 75-76
24. Walker K., Perkins M., and Dray A. kinins and kinins receptors in the nervous system. Neurochem. Int. 26 (1995) 1-16
25. Xia C.F., Yin H., Borlongan C.V., Chao L., and Chao J. Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis. Hypertension 43 (2004) 452-459
26. Xia C.F., Smith Jr. R.S., Shen B., Yang Z.R., Borlongan C.V., Chao L., and Chao J. postischemic brain injury is exacerbated in mice lacking the kinin B2 receptor. Hypertension 47 (2006) 752-761
27. Yang C.M., Chien C.S., Ma Y.H., Hsiao L.D., Lin C.H., and Wu C. Bradykinin B2 receptor-mediated proliferation via activation of the Ras/Raf/MEK/MAPK pathway in rat vascular smooth muscle cells. J. Biomed. Sci. 10 (2003) 208-218
28. Yin H., Chao J., Bader M., and Chao L. Differential role of kinin B1 and B2 receptors in ischemia-induced apoptosis and ventricular remodeling. Peptides 28 (2007) 1383-1389
29. Yuan J.Y., and Yankner B.A. Apoptosis in the nervous system. Nature 407 (2000) 802-809
30. Zausinger S., Lumenta D.B., Pruneau D., Schmid-Elsaesser R., Plesnila N., and Baethmann A. Effects of LF 16-0687 Ms, a bradykinin B2 receptor antagonist, on brain edema formation and tissue damage in a rat model of temporary focal cerebral ischemia. Brain. Res. 950 (2002) 268-278